Generated by AI
908 Devices Inc. is a medical technology company that develops handheld and desktop chemical analysis instruments for point-of-need testing. Its product portfolio centers on portable mass spectrometry and spectroscopy systems used to detect, identify, and monitor unknown substances in demanding environments. The company’s devices support applications across health, safety, and defense, including field screening for hazardous chemicals, drugs, explosives, gases, and other materials that require rapid analysis outside traditional laboratories. 908 Devices also serves markets such as life sciences research, bioprocessing, biopharma, forensics, and industrial analysis with tools designed for faster, more accessible sample interrogation. Headquartered in Burlington, Massachusetts, 908 Devices focuses on making advanced analytical capabilities available in compact formats that can be used directly at the point of need.
Website44 3rd Avenue
Burlington, MA, 01803
United States
The latest articles about MASS.
908 Devices posts 35% Q3 revenue growth and record 308 device placements, raising the low end of 2026 revenue guidance to $68.5 million. See more on MASS stock.
Motley Fool Press Release.
Summary of Jan 20's posts. Generated by AI.
Summary of Mar 5's posts. Generated by AI.
Summary of Jan 16's posts. Generated by AI.
Investors talking about MASS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.